Switch to:
Biomarin Pharmaceutical Inc (NAS:BMRN)
Additional Paid-In Capital
$4,232 Mil (As of Sep. 2016)

Biomarin Pharmaceutical Inc's quarterly additional paid-in capital increased from Mar. 2016 ($3,410 Mil) to Jun. 2016 ($3,458 Mil) and increased from Jun. 2016 ($3,458 Mil) to Sep. 2016 ($4,232 Mil).

Biomarin Pharmaceutical Inc's annual additional paid-in capital increased from Dec. 2013 ($2,059 Mil) to Dec. 2014 ($2,360 Mil) and increased from Dec. 2014 ($2,360 Mil) to Dec. 2015 ($3,415 Mil).


Definition

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)*Shares Outstanding

Related Terms

Shares Outstanding


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Biomarin Pharmaceutical Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
AdditionalPaidInCapital 7097958539001,0901,1971,5622,0592,3603,415

Biomarin Pharmaceutical Inc Quarterly Data

Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16
AdditionalPaidInCapital 2,2492,2792,3603,3083,3383,3713,4153,4103,4584,232
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK